Atlas Trials

Wheat Flour Treatment With Microbial Transglutaminase and Lysine Ethyl Ester: New Frontiers in Celiac Disease Treatment.

Clinical trial NCT02472119 · UNKNOWN

Trial details

NCT number
NCT02472119
Sponsor
University of Roma La Sapienza
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Celiac Disease
Start date
2015-06-01
Primary completion
2015-08-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.